Global Genomics & Sequencing Automation Systems Market 2026 by Company, Regions, Type and Application, Forecast to 2032
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Genomics & Sequencing Automation Systems by Type
- 1.3.1 Overview: Global Genomics & Sequencing Automation Systems Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Genomics & Sequencing Automation Systems Consumption Value Market Share by Type in 2025
- 1.3.3 Automated Liquid Handling Systems
- 1.3.4 Automated Nucleic Acid Extraction Systems
- 1.3.5 NGS Library Preparation Automation Systems
- 1.3.6 Robotic Sample Processing Workstations
- 1.3.7 Integrated Genomics Automation Platforms
- 1.3.8 Sequencing Workflow Automation Systems
- 1.4 Classification of Genomics & Sequencing Automation Systems by Workflow Stage
- 1.4.1 Overview: Global Genomics & Sequencing Automation Systems Market Size by Workflow Stage: 2021 Versus 2025 Versus 2032
- 1.4.2 Global Genomics & Sequencing Automation Systems Consumption Value Market Share by Workflow Stage in 2025
- 1.4.3 Sample Accessioning and Tracking
- 1.4.4 DNA/RNA Extraction
- 1.4.5 Quantification and Quality Control
- 1.4.6 Library Preparation
- 1.4.7 Sample Normalization and Pooling
- 1.4.8 Sequencing Setup and Loading
- 1.4.9 Post-Sequencing Data Processing
- 1.5 Classification of Genomics & Sequencing Automation Systems by Throughput Level
- 1.5.1 Overview: Global Genomics & Sequencing Automation Systems Market Size by Throughput Level: 2021 Versus 2025 Versus 2032
- 1.5.2 Global Genomics & Sequencing Automation Systems Consumption Value Market Share by Throughput Level in 2025
- 1.5.3 Low-Throughput Systems
- 1.5.4 Medium-Throughput Systems
- 1.5.5 High-Throughput Systems
- 1.5.6 Ultra-High-Throughput Genomics Platforms
- 1.6 Global Genomics & Sequencing Automation Systems Market by Application
- 1.6.1 Overview: Global Genomics & Sequencing Automation Systems Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Pharmaceutical and Biotechnology Companies
- 1.6.3 Clinical Diagnostic Laboratories
- 1.6.4 Academic and Research Institutes
- 1.6.5 Contract Research Organizations (CROs)
- 1.6.6 Government and Public Health Laboratories
- 1.6.7 Population Genomics Centers
- 1.7 Global Genomics & Sequencing Automation Systems Market Size & Forecast
- 1.8 Global Genomics & Sequencing Automation Systems Market Size and Forecast by Region
- 1.8.1 Global Genomics & Sequencing Automation Systems Market Size by Region: 2021 VS 2025 VS 2032
- 1.8.2 Global Genomics & Sequencing Automation Systems Market Size by Region, (2021-2032)
- 1.8.3 North America Genomics & Sequencing Automation Systems Market Size and Prospect (2021-2032)
- 1.8.4 Europe Genomics & Sequencing Automation Systems Market Size and Prospect (2021-2032)
- 1.8.5 Asia-Pacific Genomics & Sequencing Automation Systems Market Size and Prospect (2021-2032)
- 1.8.6 South America Genomics & Sequencing Automation Systems Market Size and Prospect (2021-2032)
- 1.8.7 Middle East & Africa Genomics & Sequencing Automation Systems Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 Illumina
- 2.1.1 Illumina Details
- 2.1.2 Illumina Major Business
- 2.1.3 Illumina Genomics & Sequencing Automation Systems Product and Solutions
- 2.1.4 Illumina Genomics & Sequencing Automation Systems Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Illumina Recent Developments and Future Plans
- 2.2 Thermo Fisher Scientific
- 2.2.1 Thermo Fisher Scientific Details
- 2.2.2 Thermo Fisher Scientific Major Business
- 2.2.3 Thermo Fisher Scientific Genomics & Sequencing Automation Systems Product and Solutions
- 2.2.4 Thermo Fisher Scientific Genomics & Sequencing Automation Systems Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
- 2.3 Danaher
- 2.3.1 Danaher Details
- 2.3.2 Danaher Major Business
- 2.3.3 Danaher Genomics & Sequencing Automation Systems Product and Solutions
- 2.3.4 Danaher Genomics & Sequencing Automation Systems Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Danaher Recent Developments and Future Plans
- 2.4 Agilent Technologies
- 2.4.1 Agilent Technologies Details
- 2.4.2 Agilent Technologies Major Business
- 2.4.3 Agilent Technologies Genomics & Sequencing Automation Systems Product and Solutions
- 2.4.4 Agilent Technologies Genomics & Sequencing Automation Systems Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Agilent Technologies Recent Developments and Future Plans
- 2.5 Revvity
- 2.5.1 Revvity Details
- 2.5.2 Revvity Major Business
- 2.5.3 Revvity Genomics & Sequencing Automation Systems Product and Solutions
- 2.5.4 Revvity Genomics & Sequencing Automation Systems Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Revvity Recent Developments and Future Plans
- 2.6 Roche Diagnostics
- 2.6.1 Roche Diagnostics Details
- 2.6.2 Roche Diagnostics Major Business
- 2.6.3 Roche Diagnostics Genomics & Sequencing Automation Systems Product and Solutions
- 2.6.4 Roche Diagnostics Genomics & Sequencing Automation Systems Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Roche Diagnostics Recent Developments and Future Plans
- 2.7 QIAGEN
- 2.7.1 QIAGEN Details
- 2.7.2 QIAGEN Major Business
- 2.7.3 QIAGEN Genomics & Sequencing Automation Systems Product and Solutions
- 2.7.4 QIAGEN Genomics & Sequencing Automation Systems Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 QIAGEN Recent Developments and Future Plans
- 2.8 Hamilton Company
- 2.8.1 Hamilton Company Details
- 2.8.2 Hamilton Company Major Business
- 2.8.3 Hamilton Company Genomics & Sequencing Automation Systems Product and Solutions
- 2.8.4 Hamilton Company Genomics & Sequencing Automation Systems Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Hamilton Company Recent Developments and Future Plans
- 2.9 Tecan
- 2.9.1 Tecan Details
- 2.9.2 Tecan Major Business
- 2.9.3 Tecan Genomics & Sequencing Automation Systems Product and Solutions
- 2.9.4 Tecan Genomics & Sequencing Automation Systems Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Tecan Recent Developments and Future Plans
- 2.10 Becton Dickinson
- 2.10.1 Becton Dickinson Details
- 2.10.2 Becton Dickinson Major Business
- 2.10.3 Becton Dickinson Genomics & Sequencing Automation Systems Product and Solutions
- 2.10.4 Becton Dickinson Genomics & Sequencing Automation Systems Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Becton Dickinson Recent Developments and Future Plans
- 2.11 Eppendorf
- 2.11.1 Eppendorf Details
- 2.11.2 Eppendorf Major Business
- 2.11.3 Eppendorf Genomics & Sequencing Automation Systems Product and Solutions
- 2.11.4 Eppendorf Genomics & Sequencing Automation Systems Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Eppendorf Recent Developments and Future Plans
- 2.12 MGI Tech
- 2.12.1 MGI Tech Details
- 2.12.2 MGI Tech Major Business
- 2.12.3 MGI Tech Genomics & Sequencing Automation Systems Product and Solutions
- 2.12.4 MGI Tech Genomics & Sequencing Automation Systems Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 MGI Tech Recent Developments and Future Plans
- 2.13 BGI Genomics
- 2.13.1 BGI Genomics Details
- 2.13.2 BGI Genomics Major Business
- 2.13.3 BGI Genomics Genomics & Sequencing Automation Systems Product and Solutions
- 2.13.4 BGI Genomics Genomics & Sequencing Automation Systems Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 BGI Genomics Recent Developments and Future Plans
- 2.14 Autobio Diagnostics
- 2.14.1 Autobio Diagnostics Details
- 2.14.2 Autobio Diagnostics Major Business
- 2.14.3 Autobio Diagnostics Genomics & Sequencing Automation Systems Product and Solutions
- 2.14.4 Autobio Diagnostics Genomics & Sequencing Automation Systems Revenue, Gross Margin and Market Share (2021-2026)
- 2.14.5 Autobio Diagnostics Recent Developments and Future Plans
- 2.15 Haier Biomedical
- 2.15.1 Haier Biomedical Details
- 2.15.2 Haier Biomedical Major Business
- 2.15.3 Haier Biomedical Genomics & Sequencing Automation Systems Product and Solutions
- 2.15.4 Haier Biomedical Genomics & Sequencing Automation Systems Revenue, Gross Margin and Market Share (2021-2026)
- 2.15.5 Haier Biomedical Recent Developments and Future Plans
- 2.16 DAAN Gene
- 2.16.1 DAAN Gene Details
- 2.16.2 DAAN Gene Major Business
- 2.16.3 DAAN Gene Genomics & Sequencing Automation Systems Product and Solutions
- 2.16.4 DAAN Gene Genomics & Sequencing Automation Systems Revenue, Gross Margin and Market Share (2021-2026)
- 2.16.5 DAAN Gene Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Genomics & Sequencing Automation Systems Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Genomics & Sequencing Automation Systems by Company Revenue
- 3.2.2 Top 3 Genomics & Sequencing Automation Systems Players Market Share in 2025
- 3.2.3 Top 6 Genomics & Sequencing Automation Systems Players Market Share in 2025
- 3.3 Genomics & Sequencing Automation Systems Market: Overall Company Footprint Analysis
- 3.3.1 Genomics & Sequencing Automation Systems Market: Region Footprint
- 3.3.2 Genomics & Sequencing Automation Systems Market: Company Product Type Footprint
- 3.3.3 Genomics & Sequencing Automation Systems Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Genomics & Sequencing Automation Systems Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Genomics & Sequencing Automation Systems Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Genomics & Sequencing Automation Systems Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Genomics & Sequencing Automation Systems Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Genomics & Sequencing Automation Systems Consumption Value by Type (2021-2032)
- 6.2 North America Genomics & Sequencing Automation Systems Market Size by Application (2021-2032)
- 6.3 North America Genomics & Sequencing Automation Systems Market Size by Country
- 6.3.1 North America Genomics & Sequencing Automation Systems Consumption Value by Country (2021-2032)
- 6.3.2 United States Genomics & Sequencing Automation Systems Market Size and Forecast (2021-2032)
- 6.3.3 Canada Genomics & Sequencing Automation Systems Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Genomics & Sequencing Automation Systems Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Genomics & Sequencing Automation Systems Consumption Value by Type (2021-2032)
- 7.2 Europe Genomics & Sequencing Automation Systems Consumption Value by Application (2021-2032)
- 7.3 Europe Genomics & Sequencing Automation Systems Market Size by Country
- 7.3.1 Europe Genomics & Sequencing Automation Systems Consumption Value by Country (2021-2032)
- 7.3.2 Germany Genomics & Sequencing Automation Systems Market Size and Forecast (2021-2032)
- 7.3.3 France Genomics & Sequencing Automation Systems Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Genomics & Sequencing Automation Systems Market Size and Forecast (2021-2032)
- 7.3.5 Russia Genomics & Sequencing Automation Systems Market Size and Forecast (2021-2032)
- 7.3.6 Italy Genomics & Sequencing Automation Systems Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Genomics & Sequencing Automation Systems Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Genomics & Sequencing Automation Systems Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Genomics & Sequencing Automation Systems Market Size by Region
- 8.3.1 Asia-Pacific Genomics & Sequencing Automation Systems Consumption Value by Region (2021-2032)
- 8.3.2 China Genomics & Sequencing Automation Systems Market Size and Forecast (2021-2032)
- 8.3.3 Japan Genomics & Sequencing Automation Systems Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Genomics & Sequencing Automation Systems Market Size and Forecast (2021-2032)
- 8.3.5 India Genomics & Sequencing Automation Systems Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Genomics & Sequencing Automation Systems Market Size and Forecast (2021-2032)
- 8.3.7 Australia Genomics & Sequencing Automation Systems Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Genomics & Sequencing Automation Systems Consumption Value by Type (2021-2032)
- 9.2 South America Genomics & Sequencing Automation Systems Consumption Value by Application (2021-2032)
- 9.3 South America Genomics & Sequencing Automation Systems Market Size by Country
- 9.3.1 South America Genomics & Sequencing Automation Systems Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Genomics & Sequencing Automation Systems Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Genomics & Sequencing Automation Systems Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Genomics & Sequencing Automation Systems Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Genomics & Sequencing Automation Systems Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Genomics & Sequencing Automation Systems Market Size by Country
- 10.3.1 Middle East & Africa Genomics & Sequencing Automation Systems Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Genomics & Sequencing Automation Systems Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Genomics & Sequencing Automation Systems Market Size and Forecast (2021-2032)
- 10.3.4 UAE Genomics & Sequencing Automation Systems Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Genomics & Sequencing Automation Systems Market Drivers
- 11.2 Genomics & Sequencing Automation Systems Market Restraints
- 11.3 Genomics & Sequencing Automation Systems Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Genomics & Sequencing Automation Systems Industry Chain
- 12.2 Genomics & Sequencing Automation Systems Upstream Analysis
- 12.3 Genomics & Sequencing Automation Systems Midstream Analysis
- 12.4 Genomics & Sequencing Automation Systems Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Genomics & Sequencing Automation Systems market size was valued at US$ 6379 million in 2025 and is forecast to a readjusted size of US$ 9394 million by 2032 with a CAGR of 5.7% during review period.
Genomics & Sequencing Automation Systems are integrated laboratory automation platforms designed to streamline, standardize, and accelerate genomic research and next-generation sequencing (NGS) workflows through the automated handling of biological samples, reagents, data processing, and sequencing preparation steps. These systems combine robotic liquid handling, nucleic acid extraction modules, sample tracking technologies, library preparation automation, laboratory information management systems (LIMS), and bioinformatics software to reduce manual intervention, improve reproducibility, increase throughput, and minimize human error.
This report is a detailed and comprehensive analysis for global Genomics & Sequencing Automation Systems market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Genomics & Sequencing Automation Systems market size and forecasts, in consumption value ($ Million), 2021-2032
Global Genomics & Sequencing Automation Systems market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Genomics & Sequencing Automation Systems market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Genomics & Sequencing Automation Systems market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Genomics & Sequencing Automation Systems
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Genomics & Sequencing Automation Systems market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, Thermo Fisher Scientific, Danaher, Agilent Technologies, Revvity, Roche Diagnostics, QIAGEN, Hamilton Company, Tecan, Becton Dickinson, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Genomics & Sequencing Automation Systems market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Automated Liquid Handling Systems
Automated Nucleic Acid Extraction Systems
NGS Library Preparation Automation Systems
Robotic Sample Processing Workstations
Integrated Genomics Automation Platforms
Sequencing Workflow Automation Systems
Market segment by Workflow Stage
Sample Accessioning and Tracking
DNA/RNA Extraction
Quantification and Quality Control
Library Preparation
Sample Normalization and Pooling
Sequencing Setup and Loading
Post-Sequencing Data Processing
Market segment by Throughput Level
Low-Throughput Systems
Medium-Throughput Systems
High-Throughput Systems
Ultra-High-Throughput Genomics Platforms
Market segment by Application
Pharmaceutical and Biotechnology Companies
Clinical Diagnostic Laboratories
Academic and Research Institutes
Contract Research Organizations (CROs)
Government and Public Health Laboratories
Population Genomics Centers
Market segment by players, this report covers
Illumina
Thermo Fisher Scientific
Danaher
Agilent Technologies
Revvity
Roche Diagnostics
QIAGEN
Hamilton Company
Tecan
Becton Dickinson
Eppendorf
MGI Tech
BGI Genomics
Autobio Diagnostics
Haier Biomedical
DAAN Gene
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Genomics & Sequencing Automation Systems product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Genomics & Sequencing Automation Systems, with revenue, gross margin, and global market share of Genomics & Sequencing Automation Systems from 2021 to 2026.
Chapter 3, the Genomics & Sequencing Automation Systems competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Genomics & Sequencing Automation Systems market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Genomics & Sequencing Automation Systems.
Chapter 13, to describe Genomics & Sequencing Automation Systems research findings and conclusion.